<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90875">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02116153</url>
  </required_header>
  <id_info>
    <org_study_id>UHHD-BM-003</org_study_id>
    <nct_id>NCT02116153</nct_id>
  </id_info>
  <brief_title>Mi-RNAs and Specificity of Hs-TnT in Symptomatic ED Patients</brief_title>
  <official_title>Clinical Use of Mi-RNAs to Improve Specificity of High-sensitivity Troponin T in Symptomatic Patients Presenting to the ED</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Heart Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Biomarkers play a key role in the diagnostic workup of patients presenting to an emergency
      department (ED). European and American guidelines recommend cardiac Troponin (T or I) as the
      biomarker gold standard for the diagnosis of non-ST-elevation myocardial infarction
      (non-STEMI). Today, high-sensitivitiy assays are available and allow an early diagnosis of
      non-STEMI and the detection of troponin in individuals that would have been classified as
      unstable angina with former assays. As many patients are detected with elevated troponin
      values with the high sensitivity assays, specificity for non-STEMI has inevitably decreased.
      Micro-RNAs (mi-RNA) are new biomarkers with a wide spectrum of detectable conditions that
      allow specific identification of myocardial infarction. The aim of this study is to develop
      a biomarker protocol that combines the high sensitivity of cardiac Troponin T and the high
      specificity of mi-RNA profiles for early and safe identification of non-STEMI in ED
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myocardial Infraction</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the emergency department with symptoms suggestive of acute coronary
        syndrome.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted to the emergency department (&quot;chest pain unit&quot;), Dept. of
             Cardiology, University Hospital Heidelberg

          -  Symptoms suggestive of ACS incl. chest pain, dyspnea, atypical pain

          -  Age &gt;= 18 years

          -  Written informed consent

        Exclusion Criteria:

          -  Mental disorders, dementia

          -  Pregnancy, breast feeding

          -  Age &lt; 18 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evangelos Giannitsis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugo A Katus, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Moritz Biener, MD</last_name>
    <email>moritz.biener@med.uni-heidelberg.de</email>
  </overall_contact>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>April 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Professor Hugo Katus</investigator_full_name>
    <investigator_title>Director, Department of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Cardiac Troponin T</keyword>
  <keyword>Micro-RNA</keyword>
  <keyword>Sensitivity</keyword>
  <keyword>Specificity</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
